Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Secondary
1.7.1.1 Paid sources
1.7.1.2 Unpaid sources
1.7.2 Primary
Chapter 2 Executive Summary
2.1 Urinary tract infection testing market industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Test type trends
2.1.4 Test kit type trends
2.1.5 Application trends
2.1.6 End-use trends
Chapter 3 Urinary Tract Infection Testing Industry Insights
3.1 Industry segmentation
3.2 Industry ecosystem analysis
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of urinary tract infections globally
3.3.1.2 Growing incidence of hospital-acquired urinary tract infection
3.3.1.3 High prevalence of diabetes in low and middle-income nations
3.3.1.4 Novel product launches regarding UTI testing products
3.3.2 Industry pitfalls & challenges
3.3.2.1 False results associated with UTI testing
3.3.2.2 Stringent regulatory framework
3.4 Growth potential analysis
3.4.1 By test type
3.4.2 By test kit type
3.4.3 By application
3.4.4 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Technology landscape
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive landscape
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Competitive dashboard
4.4 Company market share, 2021
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix
Chapter 5 Urinary Tract Infection Testing Market and Forecast, By Test Type (USD Million)
5.1 Key trends, by test type
5.2 Urinalysis
5.3 Urine cultures
5.4 Susceptibility testing
Chapter 6 Urinary Tract Infection Testing Market and Forecast, By Test Kit Type (USD Million)
6.1 Key trends, by test kit type
6.2 Laboratory test kits
6.3 Home test kits
Chapter 7 Urinary Tract Infection Testing Market and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Urethritis
7.3 Cystitis
7.4 Pyelonephritis
Chapter 8 Urinary Tract Infection Testing Market and Forecast, By End-use (USD Million)
8.1 Key trends, by end-use
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Homecare settings
8.5 Others
Chapter 9 Urinary Tract Infection Testing Market and Forecast, By Region (USD Million)
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Russia
9.3.7 Poland
9.3.8 Switzerland
9.3.9 Norway
9.3.10 Finland
9.3.11 Sweden
9.3.12 Denmark
9.3.13 The Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Taiwan
9.4.7 Indonesia
9.4.8 Vietnam
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Colombia
9.5.5 Chile
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Israel
Chapter 10 Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.2 Bio-Rad Laboratories
10.3 Danaher Corporation
10.4 ACON Laboratories Inc.
10.5 Cardinal Health Inc.
10.6 Stryker Corporation
10.7 SYSMEX CORPORATION
10.8 Abbott Laboratories
10.9 F. Hoffmann-La Roche Ltd
10.10 LabCorp(Laboratory Corporation of America Holdings)
10.11 Siemens Healthineers Inc.
